Abstract: Disclosed is a process for the preparation of mono-epoxides of certain diolefins wherein a conjugated diolefin, or polyolefin, that contains allylic carbon-hydrogen bonds, is contacted with molecular oxygen in the presence of a modified silver catalyst.
Type:
Grant
Filed:
May 24, 2001
Date of Patent:
May 14, 2002
Assignee:
Eastman Chemical Company
Inventors:
John Robert Monnier, Kimberly Thornton Peters
Abstract: New taxoids of general formula (I):
their preparation and pharmaceutical compositions containing them. The new products of general formula (I) in which Z represents a radical of general formula (II):
display noteworthy antitumour and antileukaemic properties.
Abstract: The present invention generally provides taxane prodrugs comprising at least one taxane joined by hydrolyzable bond(s) to one or more polyethylene glycol oligomer(s) selected from the group consisting of a straight or branched polyethylene glycol oligomer having from 1 to 25 polyethylene glycol units and optionally comprising a salt-forming moiety. The polyethylene glycol oligomer preferably comprises a salt-forming moiety, which is preferably selected from the group consisting of ammonium and carboxylate.
Type:
Grant
Filed:
December 31, 1999
Date of Patent:
April 30, 2002
Assignee:
Nobex Corporation
Inventors:
Nnochiri Ekwuribe, Gary S. Bartley, Christopher H. Price
Abstract: A process for forming an olefin epoxidation catalyst is described. The process comprises reacting a tert-alkyl trihydroxysilane with a titanium complex such that the ratio of Si:Ti is 7. The catalyst is very active and selective in olefin epoxidation.
Abstract: The invention is an olefin epoxidation process that comprises reacting olefin, oxygen, and hydrogen in a liquid medium in the presence of an epoxidation catalyst in a reactor system comprising a tank, a tube, a plurality of impellers, and means for inhibiting flow. The reactor system facilitates transfer of the hydrogen and oxygen to the liquid medium.
Abstract: There is provided a process for the vapor phase oxidation of ethylene to ethylene oxide in the presence of a supported highly selective silver-based catalyst, the process comprising operating fresh catalyst for an initial operation phase, then operating at a further operation phase when the catalyst has reached an advanced aged defined by a cumulative ethylene oxide production exceeding 1.5 kT EO per m3 of catalyst. In the further operation phase the composition of the reaction mixture is changed to contain from 1.1 to 4 times the concentration of ethylene used in the initial operation phase and the corresponding optimised and safe concentration of oxygen.
Type:
Grant
Filed:
December 12, 2000
Date of Patent:
April 16, 2002
Assignee:
Shell Oil Company
Inventors:
Wayne Errol Evans, Peter Ingraham Chipman
Abstract: The present invention relates to a process for the production of (−)3,4-divanillyl tetrahydrofiran of formula (2) which comprises (a) isolating) (−) secoisolariciresinol of formula (1) from the heartwood and roots of Taxus wallichiana by an improved process which consists of partitioning of the alcoholic extract of the heartwood and roots of T. wallichiana between water and chlorinated solvent, (b) extracting the chlorinated solvent extract with alkali and (c) isolating (−) secoisolariciresinol from the alkali extract upon neutralization with mineral acid and extracting with organic solvent and (d) crystallizing it from suitable organic solvent, (e) dissolving the isolated (−) secoisolariciresinol in suitable organic solvent and (f) reacting with triphenyl phosphine halide at 0-80° C. for 1-10 hours and (g) isolating (−) 3,4-divanillyl tetrahydrofuran by column chromatography.
Type:
Grant
Filed:
March 27, 2001
Date of Patent:
April 16, 2002
Assignee:
Council of Scientific and Industrial Research
Abstract: Now taxoids of general formula (I)
their preparation and pharmaceutical compositions containing them.
The new products of general formula (I) in which Z represents a radical of general formula (II):
display noteworthy antitumor and antileukaemic properties.
Abstract: Novel oxazolidines finding utility as intermediates in the preparation of C-13 acyloxy sidechain-bearing taxanes such as paclitaxel and analogs thereof. The present invention also relates to novel methods of coupling the oxazolidines to form the aforementioned taxanes, and to methods of preparing the oxazolidines.
Type:
Grant
Filed:
May 20, 1999
Date of Patent:
April 2, 2002
Assignee:
Bristol Myers Squibb Comp.
Inventors:
John K. Thottathil, Ivan D. Trifunovich
Abstract: Process for the preparation of alkylene oxide, which process comprises passing a feed comprising an organic hydroperoxide and alkene through a bank of at least two serially connected reactors all containing a bed of heterogeneous epoxidation catalyst particles and operated in a cyclic mode, in which process:
(a) the first reactor of the cyclically operated bank is put in a position further down this bank, when the activity of the epoxidation catalyst contained therein has decreased to an undesirably low level;
(b) in this position the catalyst with decreased activity is contacted with the effluent from the reactor in the preceding position at a temperature which is at least 5° C. higher than the final temperature at which the catalyst was in use in the first position of the bank and for sufficient time to restore its activity to the desired level.
Type:
Grant
Filed:
June 8, 2000
Date of Patent:
April 2, 2002
Assignee:
Shell Oil Company
Inventors:
Willem Derks, Hendrik Dirkzwager, Alexander Jan Van Der Veen, Rutger Johannes Franciscus Wermeling
Abstract: A process for the direct oxidation of an olefin by oxygen to the corresponding olefin oxide in the presence of a reducing agent and a catalyst. The catalyst comprises a metal component, such as a transition metal oxide, dispersed on a metal ion-exchanged metallosilicates, such as a Group 1 or Group 2 ion-exchanged porous aluminosilicate. Selectivity to the olefin oxide is high and the catalyst is readily regenerated.
Type:
Grant
Filed:
October 4, 2000
Date of Patent:
March 26, 2002
Assignee:
The Dow Chemical Company
Inventors:
Alex Kuperman, Robert G. Bowman, Howard W. Clark, George E. Hartwell
Abstract: Taxanes having a carbamoyloxy substituent at C(7), a hydroxy substituent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.
Abstract: The invention relates to improved methods of producing aryl dioxoalkanoic acid compounds and derivatives useful as intermediates for diarylpyrrole therapeutic agents by the alcoholysis of benzoylcyclohexanone ketal compounds.
Abstract: The present invention relates to a catalytic process for the preparation of 3-hydroxymethyl tetrahydrofuran of formula IV
with hydroformylation as one of the key steps. The process comprises reacting 9-hydroxymethyl-7,12-dioxaspiro[5,6]dodecane of the formula III
with an alcohol in the presence of an acid catalyst and recovering the 3-hydroxymethyl tetrahydrofuran.
Type:
Grant
Filed:
February 28, 2001
Date of Patent:
March 12, 2002
Assignee:
Council of Scientific and Industrial Research of India
Inventors:
Pardhasaradhi Malladi, Sri Nagesh Kumar Potluri
Abstract: A stereospecific method for accomplishing the below reaction:
results in the compound of formula 2 having the same stereochemistry at both carbon 1 and carbon 3 as that in the compound of formula 1. Thus, if carbon 3 is in the R-configuration in the compound of formula 1, then carbon 3 will be in the R-configuration in the compound of resulting formula 2. In the above process, R1 is C1-C6 alkyl that can be straight-chain or branched. The process functions using a fluorinated alcohol having a pKa less than about 9, in the presence of a palladium catalyst. The compounds of formula 1, as well as novel intermediates in this process, are useful in manufacturing vitamin D analogs.
Type:
Grant
Filed:
April 16, 2001
Date of Patent:
March 5, 2002
Assignee:
Hoffmann-La Roche Inc.
Inventors:
Andrzej Robert Daniewski, Marek Michal Kabat, Masami Okabe, Roumen Nikolaev Radinov
Abstract: Disclosed is a process for separating 2,5-dihydrofuran (2,5-DHF) from aqueous solution of 2,5-DHF by extractive distillation using certain organic liquids as the extraction agent.
Abstract: A process for the synthesis of a C-4 methyl carbonate paclitaxel analog from 10-deacetylbaccatin III by the selective reduction of the acetate at the C-4 position of 10-deacetylbaccatin using Red-Al.
Abstract: Novel &bgr;-lactams finding utility as intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives. The present invention also relates to novel methods of coupling &bgr;-lactams to form such sidechain-bearing taxanes, and to novel sidechain-bearing taxanes.
Type:
Grant
Filed:
May 12, 1995
Date of Patent:
February 26, 2002
Assignee:
Bristol-Myers Squibb Company
Inventors:
John K. Thottathil, Ivan D. Trifunovich, David J. Kucera, Wen-Sen Li